THEVAX Genetics Vaccine   Report issue

For profit Phase 2
Founded: Taipei Taiwan (2012)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2015
NCT02576561
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now